Form 4 for CNO CNO Financial Group, Inc.
Accepted 2026-09-16 18:09:34 ET · period of report 2026-09-15 · accession 0002006641-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-16 18:09 | 2026-09-15+ | CNO | Williams Jeremy D. | Chief Actuary | M - OptEx | $22.02 | +7,660 | 65.4K | +13% | +$168.7K |
| DMT | 2026-09-16 18:09 | 2026-09-15+ | CNO | Williams Jeremy D. | Chief Actuary | S - Sale+OE | $55.49 | -8,782 | 61.0K | -13% | -$487.3K |
| DMT | 2026-09-16 18:09 | 2026-09-15+ | CNO | Williams Jeremy D. | Chief Actuary | M - OptEx | $0.00 | -7,660 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | M | A | 4,420 | $21.06 | 66,583 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-15 | S | D | 4,420 | $55.27 | 62,163 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. (F2) Reflects the weighted average sale price. Shares were sold at prices ranging from $55.01 per share to $55.50 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 3 | Common | Common Stock | 2026-09-16 | M | A | 3,240 | $23.33 | 65,403 | D | — | — | |
| 4 | Common | Common Stock | 2026-09-16 | S | D | 3,240 | $55.71 | 62,163 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. (F3) Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.84 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 5 | Common | Common Stock | 2026-09-16 | S | D | 1,122 | $55.72 | 61,041 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026. (F4) Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.82 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2026-09-15 | M | D | 4,420 | $0.00 | 0 | D | $21.06 · — to 2027-02-23 | 4,420 Common Stock | (F5) One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2026-09-16 | M | D | 3,240 | $0.00 | 0 | D | $23.33 · — to 2028-02-21 | 3,240 Common Stock | (F6) One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021. |